eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
1/2021
vol. 37
 
Share:
Share:
more
 
 
Review paper

Development of a preterm baby – an overview of current knowledge

Marta Młodawska
1
,
Grażyna Pazera
2
,
Jakub Młodawski
1

1.
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2.
Clinic of Neonatology, Provincial Combined Hospital, Kielce, Poland
Medical Studies/Studia Medyczne 2021; 37 (1): 65–69
Online publish date: 2021/03/31
Article file
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 

Introduction

Research is still underway to identify the risk factors influencing the child’s delay or abnormal development. We try to eliminate the risk factors that impair its course to optimize conditions for proper development. The child’s development depends on the interaction of hereditary and environmental factors. Genetic factors determine the potential for development, and environmental factors define the extent to which this potential is achieved. The first year of life is an exceptionally intensive brain development period. The process of synaptogenesis and myelinization of the central nervous system is particularly sensitive to deficiency factors. Infants born prematurely lose optimal conditions at birth, and their further development is dependent on the environment affecting their immature organism. Preterm babies are at risk of impaired psychomotor development, including cognitive, neurological, and/or sensory outcomes. Literature data on long-term psychomotor development of preterm newborns are limited due to differences in research methods, clinical practices, and significant changes in perinatal care over the years. The progress of perinatal care in recent decades has undoubtedly improved the survival of preterm newborns, especially in the 23rd and 24th weeks of pregnancy [wks] group [1], but it is unknown how it has influence their psychomotor development. Some studies present the improvement of neurodevelopmental outcome in preterm newborns along with the improvement of survival [2, 3], while others do not confirm this [4, 5]. When evaluating the psychomotor development of preterm newborns, it seems very important to select an appropriate cohort, because the neonatological interventions used 20 years ago are clearly different from those used recently, which may significantly affect the reliability of the data.

The significance of obstetric-neonatological interventions

Some obstetric and neonatological interventions have a direct or indirect impact on psychomotor development of infant, e.g. by reducing the incidence of periventricular-intraventricular haemorrhage (PIVH). Antenatal corticosteroid therapy not only reduces perinatal mortality and the time of mechanical ventilation, but also reduces the risk of intraventricular haemorrhage, weakened psychomotor development, and the frequency of moderate and severe cerebral palsy (CP) incidence [6, 7]. Prenatal therapy with magnesium sulphate in the mother reduces the risk of CP and severe motor dysfunctions in the newborn, compared to newborns whose mothers have not received such therapy [8]. Advanced methods of non-invasive neonatal ventilation and improved strategy in mechanical ventilation reduce the risk of complications due to prematurity and indirectly influences psychomotor development. Avoiding postpartum steroid therapy in newborns reduce the risk of CP [9]. Some interventions such as surfactant therapy, despite increasing the survival of preterm newborns, have no direct effect on improving psychomotor development. Others, like erythropoietin therapy, have no beneficial effect both on survival and neurodevelopment in extremely preterm infants [10]. A multicentre study showed no significant differences in the incidence of death, intracranial haemorrhage, bronchopulmonary dysplasia (BP), or severe neurodevelopmental impairment at 2 years of age in an erythropoietin group compared to placebo [10].

Risk factors

The challenge of today’s neonatology is to identify patients at risk of impaired psychomotor development and early implementation of appropriate support and treatment. Based on observational studies of large populations (includes extreme premature infants (born < 28 wks)), risk factors include newborns with multiple birth defects [11], newborns with severe PIVH or periventricular leukomalacia or other abnormalities of the brain white matter [12], newborns with severe hypoxia, meningitis, trauma or respiratory failure requiring mechanical ventilation during hospitalization. The risk factor of severe hypoxia in the prenatal, perinatal, or postnatal period undoubtedly predisposes to impaired psychomotor development in the future [13], but it is worth noting that a large proportion of children born in acidosis may not develop neurological complications in the future, and most children with CP are born with normal cord blood gasometry [8, 14]. Intrauterine growth restriction and small for gestational age newborns [15–17] or poor postnatal growth in preterm infants, especially of the head [18], are further important risk factors. On the other hand, a 2006 study showed that weight gain of extremely low birth weight (ELBW) newborns during hospitalization in a neonatal intensive care unit (NICU) had a significant and independent effect on neurodevelopmental and growth outcomes at 18 to 22 months’ corrected age [19]. Preterm birth-associated neonatal conditions, which are also risk factors for impaired psychomotor development, include complications such as BPD [20, 21], NEC, sepsis, and retinopathy of prematurity (ROP). Surgical procedures during the course of their initial hospital admission increase the risk of major neurosensory disability at 8 years of life [22]. The risk of impairing psychomotor development increases with a reduction in gestational age (GA) and birth weight (BW) [23, 24]. In addition, the twin pregnancy in preterm infants with body weight < 1,000 g is the independent risk factor of death or neurodevelopmental impairment at 18 to 22 months’ corrected age [25]. Literature data also indicate that among children born < 28 wks, boys had a higher prevalence of cognitive, neurological, and behavioural deficits than girls [26]. Environmental factors that improve cognition and speech-language function include sensitive parenting [27] and a higher level of maternal education [28]. However, no correlation between the level of the mother’s education and the improvement of motor development has been demonstrated.

Neurodevelopmental outcome

The complex concept of neurodevelopmental outcome covers cognitive, neurological, and/or sensory outcomes (hearing, visual acuity). In order to include neurodevelopmental deficit as an endpoint in scientific research, it is necessary to demonstrate it using standardized scales such as Bayley Scales of Infant Development, Gross Motor Function Classification System (GMFCS) specific cognitive, or neurological or sensory outcomes. Behavioural, psychological, and functional outcomes are becoming more and more important because they seem to be equally crucial elements of long-term neurodevelopment. Preterm newborns have a higher risk of impaired psychomotor development than full-term newborns, and this risk increases with lowering foetal age [23]. A 2018 meta-analysis showed that despite advances in neonatology, preterm infants (< 37 wks) still have lower reading, counting, and writing skills at 5 years of age, compared to full-term infants, and are 3 times more likely to need special educational assistance [29]. In addition, the study showed that preterm children with BPD are at particular risk for poor academic outcome, which, among others, may be due to the fact that the BPD frequency is increasing among neonates with extremely low BW and GA [30]. Preterm infants are more likely to show behavioural and psychological problems compared to full-term babies [31]. These children more often develop attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, emotional and conduct problems (including anxiety and depression) or difficulties in contacts with peers. According to the literature data, the highest risk of developing such disorders is found in extremely (< 28 wks) or very preterm infants (< 32 wks). According to the reports of the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network, one-third of newborns born < 27 wks showed behavioural disorders at 18–22 months of the corrected age, and one-fourth have deficits in socioemotional competence [32]. Preterm infants are more likely to show medical and social disabilities in adulthood than full-term babies. Probably due to impaired cognitive skills, preterm infants, especially those with BW below 1500 g or GA below 32 weeks, have learning difficulties and therefore lower educational achievement. Cognitive skills presented by the mean cognitive test scores decrease with lower foetal age, and higher socioeconomic indicators seem to lower the effect of GA on cognitive test scores by 26% to 33% [33]. Preterm infants are in adult life less likely to have a permanent job, have lower earnings, experience an independent life less frequently [34, 35], and have an increased risk of disability, such as CP (relative risk for birth at 23 to 27 wks, 78.9; 95% confidence interval (CI): 56.5–110) [36]. Despite the burden of disability, adults born as ELBW infants describe their health-related quality of life as satisfactory. Structural brain damage is not only the greatest risk factor for impaired psychomotor development, but also a risk factor for developing psychiatric diseases [37, 38]. Premature infants also show an increased risk of problems with complex language function [39].

Predicting outcome methods

Apart from imaging tests, such as cranial ultrasonography (CrUSS) or magnetic resonance imaging of the central nervous system (CNS MRI), the most important prognostic method of assessing the development of newborns from risk groups is regular clinical neurological evaluation in the first 2 years of life. This assessment covers motor, social, and cognitive development as well as speech, vision, and hearing status. Although assessment of the neurodevelopmental outcome in school-age children seems to be more reliable due to the continuous development of the brain in the first years of life [40, 41], regular neurological assessment in the first 2 years of life allows the identification of children with severe developmental disorders that will not withdraw spontaneously later in life. This group of children comprise the greatest beneficiaries of the implementation of early therapeutic interventions [40, 42, 43]. Due to its plasticity, the brain of a premature infant has the ability to regain and take over the lost function of other brain areas. There are several methods of assessing psychomotor development in children in the first 2 years of life. The most popular and widely used, the Bayley scale, provides cognitive, language, and motor scores, and assesses social-emotional and adaptive behaviour up to 42 months. Another one, the Griffiths III is applied from birth to 72 months and examines the foundations of learning, language and communication; eye-hand coordination (including fine motor and visual perception); gross motor; and personal-social-emotional (including independent strengths and needs). Munich Functional Developmental Diagnosis (MFDD) is a less popular but interesting tool for assessing psychomotor development and diagnosing disorders. It is a method of assessing the psychomotor development of a child from the first month of life. The research tools are standardized tables of physical development according to Hellbrugge and Pechstein [44]. It studies 8 basic functions of psychomotor development: crawling, sitting, walking, grasping, perception, speaking, speech understanding, and social skills. The tables contain the standard pattern for a given function in each month of life. For preterm babies, using the corrected age of life is necessary. MFDD uses categorial assessment. It consists of assessing whether the task has been solved or not. Gradation of the assessment is not expected. Thanks to this, the method maintains high objectivity and avoids subjective evaluations. This method is especially important for premature infants, because it describes in detail the state of psychophysical development, avoiding global generalizations.

Conclusions

Despite huge progress in the field of neonatology, prematurely born infants still remain at risk of weakened psychomotor development, and this risk increases as the foetal age and birth weight decreases. In addition, preterm infants statistically more often manifest disorders in the area of behavioural, psychological, and functional outcomes compared to full-term newborns. Knowledge of risk factors of impaired psychomotor development is extremely important in identifying patients in whom regular neurological evaluation and early implementation of therapeutic interventions can bring many benefits and improve prognosis for further development. Specially standardized scales such as Bayley Scales or Munich Functional Developmental Diagnosis are used to assess psychomotor development.

Acknowledgments

This work was supported by the program of the Minister of Science and Higher Education under the name “Regional Initiative of Excellence in 2019-2022” project number: 024/RID/2018/19, financing amount: 11,999,000.00 PLN.

Conflict of interest

The authors declare no conflict of interest.

References

1. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, Van Meurs KP, Wyck-
2. off M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D’Angio CT, DeMauro SB, Truog WE, Devaskar. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314: 1039-1051.
3. Courchia B, Berkovits MD, Bauer CR. Cognitive impairment among extremely low birthweight preterm infants from 1980 to present day. J Perinatol 2019; 39: 1098.
4. Adams-Chapman I, Heyne RJ, DeMauro SB, Duncan AF, Hintz SR, Pappas A, Vohr BR, McDonald SA, Das A, Newman JE, Higgins RD. Follow-up study of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental impairment among extremely preterm infants in the Neonatal Research Network. Pediatrics 2018; 141: e20173091.
5. Hintz SR, Kendrick DE, Wilson-Costello DE, Das A, Bell EF, Vohr BR, Higgins RD, NICHD Neonatal Research Network. Early-childhood neurodevelopmental outcomes are not improving for infants born at < 25 weeks’ gestational age. Pediatrics 2011; 127: 62.
6. Cheong JLY, Anderson PJ, Burnett AC, Roberts G, Davis N, Hickey L, Carse E, Doyle LW; Victorian Infant Collaborative Study Group. Changing neurodevelopment at 8 years in children born extremely preterm since the 1990s. Pediatrics 2017; 139: e20164086.
7. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, Andrews WW, Wallace D, Das A, Bell EF, Walsh MC, Laptook AR, Shankaran S, Poindexter BB, Hale EC, Newman NS, Davis AS, Schibler K, Kennedy KA, Sánchez PJ, Van Meurs KP, Goldberg RN. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. JAMA 2011; 306: 2348-2358.
8. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017; 3: CD004454.
9. Mlodawski J, Mlodawska M, Pazera G, Michalski W, Domanski T, Dolecka-Slusarczyk M, Gluszek S, Rokita W. Cerebral palsy and obstetric-neonatological interventions. Ginekol Pol 2019; 90: 722-727.
10. Doyle LW, Ehrenkranz RA, Halliday HL. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014; 5: CD001145.
11. Juul SE, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, Robinson T, Ahmad KA, Bendel-Stenzel E, Baserga M, LaGamma EF, Downey LC, Rao R, Fahim N, Lampland A, Frantz Iii ID, Khan JY, Weiss M, Gilmore MM, Ohls RK, Srinivasan N, Perez JE, McKay V, Vu PT. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med 2020; 382: 233-243.
12. Walden RV, Taylor SC, Hansen NI, Poole WK, Stoll BJ, Abuelo D, Vohr BR. National Institute of Child Health and Human Development Neonatal Research Network. Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes. Pediatrics 2007; 120: e1512.
13. Cheong JLY, Lee KJ, Boland RA, Spittle AJ, Opie GF, Burnett AC, Hickey LM, Roberts G, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group. Changes in long-term prognosis with increasing postnatal survival and the occurrence of postnatal morbidities in extremely preterm infants offered intensive care: a prospective observational study. Lancet Child Adolesc Health 2018; 2: 872-879.
14. Michalska A Markowska M, Śliwiński Z, Pogorzelska J. Quality of life in children and young people with tetraplegic cerebral palsy. Medical Studies 2018; 34: 112-119.
15. Executive summary. Neonatal encephalopathy and neurologic outcome, second ediction. Ereport of the American College of Obstetricians and Gynecologist’s Task Force on Neonatal Encephalopathy. Obset Gynecol 2014; 123: 896-901.
16. Guellec I, Lapillonne A, Renolleau S, Charlaluk ML, Roze JC, Marret S, Vieux R, Monique K, Ancel PY; EPIPAGE Study Group. Neurologic outcomes at school age in very preterm infants born with severe or mild growth restriction. Pediatrics 2011; 127: e883.
17. De Jesus LC, Pappas A, Shankaran S, Li L, Das A, Bell EF, Stoll BJ, Laptook AR, Walsh MC, Hale EC, Newman NS, Bara R, Higgins RD; Eunice Kennedy Shriver National Institute of Health and Human Development Neonatal Research Network. Outcomes of small for gestational age infants born at < 27 weeks’ gestation. J Pediatr 2013; 163: 55-60.
18. Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of intrauterine growth restriction and small for gestational age status with childhood cognitive outcomes: a systematic review and meta-analysis. JAMA Pediatr 2020; 174: 772-781.
19. Scharf RJ, Stroustrup A, Conaway MR, DeBoer MD. Growth and development in children born very low birthweight. Arch Dis Child Fetal Neonatal 2016; 101: F433-F438.
20. Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006; 117: 1253-1261.
21. Laughon M, O’Shea MT, Allred EN, Bose C, Kuban K, Van Marter LJ, Ehrenkranz RA, Leviton A; ELGAN Study Investigators. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks’ gestation. Pediatrics 2009; 124: 637-648.
22. Twilhaar ES, Wade RM, de Kieviet JF, van Goudoever JB, van Elburg RM, Oosterlaan J. Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression. JAMA Pediatr 2018; 172: 361-367.
23. Hunt RW, Hickey LM, Burnett AC, Anderson PJ, Cheong JLY, Doyle LW; Victorian Infant Collaborative Study group. Early surgery and neurodevelopmental outcomes of children born extremely preterm. Arch Dis Child Fetal Neonatal Ed 2018; 103: F227-F232.
24. Serenius F, Källén K, Blennow M, Ewald U, Fellman V, Holmström G, Lindberg E, Lundqvist P, Maršál K, Norman M, Olhager E, Stigson L, Stjernqvist K, Vollmer B, Strömberg B; EXPRESS Group. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA 2013; 309: 1810-1820.
25. Gargus RA, Vohr BR, Tyson JE, High P, Higgins RD, Wrage LA, Poole K. Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months. Pediatrics 2009; 124: 112-121.
26. Wadhawan R, Oh W, Perritt RL, McDonald SA, Das A, Poole WK, Vohr BR, Higgins RD. Twin gestation and neurodevelopmental outcome in extremely low birth weight infants. Pediatrics 2009; 123: e220.
27. Kuban KC, Joseph RM, O’Shea TM, Allred EN, Heeren T, Douglass L, Stafstrom CE, Jara H, Frazier JA, Hirtz D, Leviton A; Extremely Low Gestational Age Newborn (ELGAN) Study Investigators. Girls and boys born before 28 weeks gestation: risks of cognitive, behavioral, and neurologic outcomes at age 10 years. J Pediatr 2016; 173: 69-75.
28. Wolke D, Jaekel J, Hall J, Baumann N. Effects of sensitive parenting on the academic resilience of very preterm and very low birth weight adolescents. J Adolesc Health 2013; 53: 642-647.
29. Luu TM, Vohr BR, Allan W, Schneider KC, Ment LR. Evidence for catch-up in cognition and receptive vocabulary among adolescents born very preterm. Pediatrics 2011; 128: 313-322.
30. Twilhaar ES, de Kieviet JF, Aarnoudse-Moens CS, van Elburg RM, Oosterlaan J. Academic performance of children born preterm: a meta-analysis and meta-regression. Arch Dis Child Fetal Neonatal Ed 2018; 103: F322.
31. Short EJ, Klein NK, Lewis BA. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: e359-e366.
32. Chiorean A, Savoy C, Beattie K, El Helou S, Silmi M, Van Lieshout RJ. Childhood and adolescent mental health of NICU graduates: an observational study. Arch Dis Child 2020; 105: 684-689.
33. Peralta-Carcelen M, Carlo WA, Pappas A, Vaucher YE, Yeates KO, Phillips VA, Gustafson KE, Payne AH, Duncan AF, Newman JE, Bann CM, Follow Up Committee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Network. Behavioral problems and socioemotional competence at
34. 18 to 22 months of extremely premature children. Pediatrics 2017; 139(6). DOI: 10.1542/peds.2016-1043.
35. Ekeus C, Lindström K, Lindblad F, Rasmussen F, Hjern A. Preterm birth, social disadvantage, and cognitive competence in Swedish 18- to 19-year-old men. Pediatrics 2010; 125: e67.
36. Breeman LD, Jaekel J, Baumann N, Bartmann P, Wolke D. Preterm cognitive function into adulthood. Pediatrics 2015; 136: 415-423.
37. Saigal S, Day KL, Van Lieshout RJ, Schmidt LA, Morrison KM, Boyle MH. Health, wealth, social integration, and sexuality of extremely low-birth-weight prematurely born adults in the fourth decade of life. JAMA Pediatr 2016; 170: 678-686.
38. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359: 262-273.
39. Luu TM, Ment LR, Schneider KC, Katz KH, Allan WC, Vohr BR. Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age. Pediatrics 2009; 123: 1037-1044.
40. Whitaker AH, Feldman JF, Lorenz JM, McNicholas F, Fisher PW, Shen S, Pinto-Martin J, Shaffer D, Paneth N. Neonatal head ultrasound abnormalities in preterm infants and adolescent psychiatric disorders. Arch Gen Psychiatry 2011; 68: 742-752.
41. van Noort-van der Spek IL, Franken MC, Weisglas-Kuperus N. Language functions in preterm-born children: a systematic review and meta-analysis. Pediatrics 2012; 129: 745-754.
42. Ment LR, Vohr B, Allan W, Katz KH, Schneider KC, Westerveld M, Duncan CC, Makuch RW. Change in cognitive function over time in very low-birth-weight infants. JAMA 2003; 289: 705-711.
43. Erdei C, Austin NC, Cherkerzian S, Morris AR, Woodward LJ. Predicting school-aged cognitive impairment in children born very preterm. Pediatrics 2020; 145: e20191982.
44. Wong HS, Santhakumaran S, Cowan FM, Modi N; Medicines for Neonates Investigator Group. Developmental assessments in preterm children: a meta-analysis. Pediatrics 2016; 138: e20160251.
45. Doyle LW, Cheong JL, Burnett A, Roberts G, Lee KJ, Anderson PJ; Victorian Infant Collaborative Study Group. Biological and social influences on outcomes of extreme-preterm/low-birth weight adolescents. Pediatrics 2015; 136: e1513-20.
46. Hellbrügge T, Pechstein J. Entwicklungsphysiologische Tabellen für Säuglingsalter. Fortschr Med 1968; 86: 481-483, 608-609.
Copyright: © 2021 Jan Kochanowski University in Kielce This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe